OGEN
AMEX Oragenics, Inc.$0.4349 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4349, $0.0189 below the day’s high of $0.4538
- YTD change
- -44.47%
- vs 20-day SMA
- -9.03%
- vs 200-day SMA
- -31.12%
Price ranges
Price & Performance
-0.25 (-36.05%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $19,800.0000
- OGEN is down 44% since the beginning of the year
- OGEN is down 67% over the past 12 months
- OGEN is down 16% over the past 1 month
- 19% of all OGEN investors are betting against OGEN
- Number of investors short OGEN has gone up 6% versus last month
OGEN reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -66.5%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -6.07%
- vs 8-day SMA
- -5.24%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Lakewood Ranch, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
